Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 409

1.
2.

Role of genetic prothrombotic risk factors in childhood caval vein thrombosis.

Münchow N, Kosch A, Schobess R, Junker R, Auberger K, Nowak-Göttl U.

Eur J Pediatr. 1999 Dec;158 Suppl 3:S109-12.

PMID:
10650847
3.

Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia.

Junker R, Koch HG, Auberger K, Münchow N, Ehrenforth S, Nowak-Göttl U.

Arterioscler Thromb Vasc Biol. 1999 Oct;19(10):2568-72.

4.

Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis.

Gemmati D, Serino ML, Moratelli S, Tognazzo S, Ongaro A, Scapoli GL.

Haemostasis. 2001 Mar-Apr;31(2):99-105.

PMID:
11684865
5.

Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. For the Childhood Thrombophilia Study Group.

Heller C, Schobess R, Kurnik K, Junker R, Günther G, Kreuz W, Nowak-Göttl U.

Br J Haematol. 2000 Nov;111(2):534-9.

PMID:
11122096
6.

Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.

Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F.

Haematologica. 2000 Dec;85(12):1271-6.

7.
8.

The 677T genotype of the common MTHFR thermolabile variant and fasting homocysteine in childhood venous thrombosis.

Koch HG, Nabel P, Junker R, Auberger K, Schobess R, Homberger A, Linnebank M, Nowak-Göttl U.

Eur J Pediatr. 1999 Dec;158 Suppl 3:S113-6.

PMID:
10650848
9.

Clinical importance of prothrombotic risk factors in pediatric patients with malignancy--impact of central venous lines.

Knöfler R, Siegert E, Lauterbach I, Taut-Sack H, Siegert G, Gehrisch S, Müller D, Rupprecht E, Kabus M.

Eur J Pediatr. 1999 Dec;158 Suppl 3:S147-50.

PMID:
10650856
10.

Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood.

Nowak-Göttl U, Sträter R, Heinecke A, Junker R, Koch HG, Schuierer G, von Eckardstein A.

Blood. 1999 Dec 1;94(11):3678-82.

11.

Prothrombotic risk factors in childhood stroke and venous thrombosis.

Heller C, Becker S, Scharrer I, Kreuz W.

Eur J Pediatr. 1999 Dec;158 Suppl 3:S117-21.

PMID:
10650849
13.

Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey.

Sträter R, Vielhaber H, Kassenböhmer R, von Kries R, Göbel U, Nowak-Göttl U.

Eur J Pediatr. 1999 Dec;158 Suppl 3:S122-5.

PMID:
10650850
14.

Prothrombotic risk factors in children with spontaneous venous thrombosis and their asymptomatic parents: a family study.

Kosch A, Junker R, Kurnik K, Schobess R, Günther G, Koch H, Nowak-Göttl U.

Thromb Res. 2000 Sep 15;99(6):531-7.

PMID:
10974337
15.

The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.

De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G.

N Engl J Med. 1999 Sep 9;341(11):801-6.

16.

A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.

Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N.

J Thromb Thrombolysis. 2005 Jun;19(3):189-96.

PMID:
16082606
17.

Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.

Lijfering WM, Middeldorp S, Veeger NJ, Hamulyák K, Prins MH, Büller HR, van der Meer J.

Circulation. 2010 Apr 20;121(15):1706-12. doi: 10.1161/CIRCULATIONAHA.109.906347. Epub 2010 Apr 5.

18.

[Factor V Leiden (G1691A) and prothrombin-G20210A alleles among patients with deep venous thrombosis and in the general population from Spain].

Francès F, Portolès O, Gabriel F, Corella D, Sorlí JV, Sabater A, Alfonso JL, Guillén M.

Rev Med Chil. 2006 Jan;134(1):13-20. Epub 2006 Mar 8. Spanish.

19.

Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.

Martinelli I, Battaglioli T, Razzari C, Mannucci PM.

J Thromb Haemost. 2007 Jan;5(1):98-101. Epub 2006 Oct 25.

20.

Prevalence of factor V Leiden and prothrombin G20210A mutation in a large French population selected for nonthrombotic history: geographical and age distribution.

Mazoyer E, Ripoll L, Gueguen R, Tiret L, Collet JP, dit Sollier CB, Roussi J, Drouet L; FITENAT Study Group.

Blood Coagul Fibrinolysis. 2009 Oct;20(7):503-10. doi: 10.1097/MBC.0b013e32832f5d7a.

PMID:
19730248

Supplemental Content

Support Center